Chemoinformaics analysis of 1-Methoxy-4-methylbenzene
Molecular Weight | 122.167 | nRot | 1 |
Heavy Atom Molecular Weight | 112.087 | nRig | 6 |
Exact Molecular Weight | 122.073 | nRing | 1 |
Solubility: LogS | -2.642 | nHRing | 0 |
Solubility: LogP | 2.583 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 1 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
nHA | 1 | APOL | 20.8299 |
nHD | 0 | BPOL | 11.7681 |
QED | 0.553 |
Synth | 1.01 |
Natural Product Likeliness | -0.645 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.008 |
HIA | 0.003 |
CACO-2 | -4.287 |
MDCK | 0.0000232 |
BBB | 0.885 |
PPB | 0.872153 |
VDSS | 2.234 |
FU | 0.097331 |
CYP1A2-inh | 0.964 |
CYP1A2-sub | 0.958 |
CYP2c19-inh | 0.914 |
CYP2c19-sub | 0.878 |
CYP2c9-inh | 0.349 |
CYP2c9-sub | 0.869 |
CYP2d6-inh | 0.374 |
CYP2d6-sub | 0.92 |
CYP3a4-inh | 0.142 |
CYP3a4-sub | 0.525 |
CL | 11.149 |
T12 | 0.677 |
hERG | 0.088 |
Ames | 0.104 |
ROA | 0.032 |
SkinSen | 0.634 |
Carcinogencity | 0.674 |
EI | 0.994 |
Respiratory | 0.105 |
NR-Aromatase | 0.005 |
Antiviral | No |
Prediction | 0.907905 |